1,025
Views
0
CrossRef citations to date
0
Altmetric
Review

The role of proteomics in defining autoimmunity

ORCID Icon
Pages 177-184 | Received 25 Feb 2021, Accepted 06 Apr 2021, Published online: 28 Apr 2021

References

  • Shampo MA, Kyle RAJ, Venter C. The human genome project. Mayo Clin Proc. 2011;86:e26–e27.
  • Willyard C. New human gene tally reignites debate. Nature. 2018;558:354–355.
  • Guttmacher AE, Collins FS. Welcome to the genomic era. N Engl J Med. 2003;349:996–998.
  • Tristani-Firouzi M. Revisiting the challenges of universal screening for long QT syndrome. J Electrocardiol. 2015;48:1053–1057.
  • Farzam K, Rajasurya V, Ahmad T. Sudden Death in Athletes. 2020 Nov 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. PMID: 30969530
  • Baczkó I, Hornyik T, Brunner M, et al. Transgenic rabbit models in proarrhythmia research. Front Pharmacol. 2020;11:853.
  • Osmak G, Baulina N, Koshkin P, et al. Collapsing the list of myocardial infarction-related differentially expressed genes into a diagnostic signature. J Transl Med. 2020;18:231.
  • Kumar D, Narang R, Sreenivas V, et al. Circulatory miR-133b and miR-21 as novel biomarkers in early prediction and diagnosis of coronary artery disease. Genes (Basel). 2020;11:164.
  • Hao YD, Ohene BE, Yang SW, et al. First-degree relatives with similar phenotypic characterisation of acute myocardial infarction: a case report and review of the literature. BMC Cardiovasc Disord. 2019;19:314.
  • Rakha EA, Pareja FG. New advances in molecular breast cancer pathology. Semin Cancer Biol. 2020;S1044–579X(20)30080-8. DOI:10.1016/j.semcancer.2020.03.014
  • Kotta S, Aldawsari HM, Badr-Eldin SM, et al. Combating the pandemic COVID-19: clinical trials, therapies and perspectives. Front Mol Biosci. 2020;7:606393.
  • Luck K, Kim DK, Lambourne L, et al. A reference map of the human binary protein interactome. Nature. 2020;580:402–408.
  • Zheng J, Haberland V, Baird D, et al. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat Genet. 2020;52:1122–1131.
  • Digre A, Lindskog C. The human protein atlas-spatial localization of the human proteome in health and disease. Protein Sci. 2021;30:218–233.
  • Consortium U. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47:D506–D515.
  • Ewing C, Ebringer R, Tribbick G, et al. Antibody activity in ankylosing spondylitis sera to two sites on HLA B27.1 at the MHC groove region (within sequence 65-85), and to a Klebsiella pneumoniae nitrogenase reductase peptide (within sequence 1-199). J Exp Med. 1990;171:1635–1647.
  • Tsuchiya N, Husby G, Williams RC Jr. Studies of humoral and cell-mediated immunity to peptides shared by HLA-27.1 and Klebsiella pneumoniae nitrogenase in ankylosing spondylitis. Clin Exp Immunol. 1989;76:354–360.
  • Schwimmbeck PL, Wu DTY, Oldstone MBA. Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and reiter’s syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med. 1987;166:173–181.
  • Schwimmbeck PL, Oldstone MBA. Autoimmune pathogenesis for ankylosing spondylitis (AS) and Reiter’s syndrome (RS): autoantibodies against an epitope shared by HLA B27 and Klebsiella pneumoniae nitrogenase in sera of patients with AS and RS. Trans Assoc Am Phys. 1987;100:28–39.
  • Schwimmbeck PL, Oldstone MBA. Molecular mimicry between human leukocyte antigen B27 and Klebsiella. Consequences for spondyloarthropathies. Am J Med. 1988;85:51–53.
  • Husby G, Tsuchiya N, Schwimmbeck PL, et al. Crossreactive epitope with Klebsiella pneumoniae nitrogenase in articular tissue of HLA-B27 positive patients with ankylosing spondylitis. Arthr Rheum. 1989;32:437–445.
  • Ogawasara M, Kono DH, Yu DTY. Mimicry of human histocompatibility HLA B27 antigens by Klebsiella pneumoniae. Infect Immun. 1986;51:901–908.
  • Wilson C, Tiwana H, Ebringer A. Molecular mimicry between HLA-DR alleles associated with rheumatoid arthritis and Proteus mirabilis as the aetiological basis for autoimmunity. Microbes Infect. 2000;2:1489–1496.
  • Oldstone MB. Molecular mimicry and immune-mediated diseases. Faseb J. 1998;12:1255–1265.
  • Comenge Y, Girard M. Multiple sclerosis and hepatitis B vaccination: adding the credibility of molecular biology to an unusual level of clinical and epidemiological evidence. Med Hypotheses. 2006;66:84–86.
  • Hernán MA, Jick SS. Hepatitis B vaccination and multiple sclerosis: the jury is still out. Pharmacoepidemiol Drug Saf. 2006;15:653–655.
  • Kanduc D, Stufano A, Lucchese G, et al. Massive peptide sharing between viral and human proteomes. Peptides. 2008;29:1755–1766.
  • Trost B, Lucchese G, Stufano A, et al. No human protein is exempt from bacterial motifs, not even one. Self Nonself. 2010;1:328–334.
  • Kanduc D, Capone G, Delfino VP, et al. The fractal dimension of protein information. Adv Stud Biol. 2010;2:53–62.
  • Kanduc D. The comparative biochemistry of viruses and humans: an evolutionary path towards autoimmunity. Biol Chem. 2019;400:629–638.
  • Santos-Sierra S. Developments in anticancer vaccination: budding new adjuvants. Biol Chem. 2020;401:435–446.
  • Pan Y, Qi Y, Shao N, et al. Nanoparticles as adjuvants to activate the complement system and to improve vaccine efficacy in vivo. Biomacromolecules. 2019;20:3575–3583.
  • Wanandy T, Honda-Okubo Y, Davies NW, et al. Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy. J Pharm Biomed Anal. 2019;172:1–8.
  • Xu Y, Wang Y, Yang Q, et al. A versatile supramolecular nanoadjuvant that activates NF-κB for cancer immunotherapy. Theranostics. 2019;9:3388–3397.
  • Liu J, Feng X, Chen Z, et al. The adjuvant effect of C(60)(OH)(22) nanoparticles promoting both humoral and cellular immune responses to HCV recombinant proteins. Mater Sci Eng C Mater Biol Appl. 2019;97:753–759.
  • Wang X, Cao F, Yan M, et al. Alum-functionalized graphene oxide nanocomplexes for effective anticancer vaccination. Acta Biomater. 2019;83:390–399.
  • Whitton JL, Fujinami RS. Viruses as triggers of autoimmunity: facts and fantasies. Curr Opin Microbiol. 1999;2:392–397.
  • Rouse BT, Deshpande S. Viruses and autoimmunity: an affair but not a marriage contract. Rev Med Virol. 2002;12:107–113.
  • Geginat J, Paroni M, Pagani M, et al. The enigmatic role of viruses in multiple sclerosis: molecular mimicry or disturbed immune surveillance? Trends Immunol. 2017;38:498–512.
  • Nicastro L, Bacterial Amyloids: TÇ. The link between bacterial infections and autoimmunity. Trends Microbiol. 2019;27:954–963.
  • Henle G, Henle W, Clifford P, et al. Antibodies to Epstein-Barr virus in Burkitt’s lymphoma and control groups. J Natl Cancer Inst. 1969;43:1147–1157.
  • Hrdinová J, D‘Angelo S, Nag G, et al. Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers. Haematologica. 2018;103:1099–1109.
  • Vlachoyiannopoulos PG, Magira E, Alexopoulos H, et al. Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19. Ann Rheum Dis. 2020;79:1661–1663.
  • Phipps WS, SoRelle JA, Li QZ, et al. SARS-CoV-2 antibody responses do not predict COVID-19 disease severity. Am J Clin Pathol. 2020;154:459–465.
  • Rijkers G, Murk JL, Wintermans B, et al. Differences in antibody kinetics and functionality between severe and mild severe acute respiratory syndrome Coronavirus 2 infections. J Infect Dis. 2020;222:1265–1269.
  • Talotta R, Robertson E. Autoimmunity as the comet tail of COVID-19 pandemic. World J Clin Cases. 2020;8:3621–3644.
  • De Boer RJ, Hogeweg P. Self-nonself discrimination due to immunological nonlinearities: the analysis of a series of models by numerical methods. IMA J Math Appl Med Biol. 1987;4:1–32.
  • Fernandes RA, Ganzinger KA, Tzou JC, et al. A cell topography-based mechanism for ligand discrimination by the T cell receptor. Proc Natl Acad Sci USA. 2019;116:14002–14010.
  • Langman RE, Cohn M. A minimal model for the self-nonself discrimination: a return to the basics. Semin Immunol. 2000;12:189–195.
  • Cohn M. Two unresolved problems facing models of the self-nonself discrimination. J Theor Biol. 2015;387:31–38.
  • Cohn M, Mitchison NA, Paul WE, et al. Reflections on the clonal-selection theory. Nat Rev Immunol. 2007;7:823–830.
  • Rose NR. Negative selection, epitope mimicry and autoimmunity. Curr Opin Immunol. 2017;49:51–55.
  • Immunobiology KD. On the inexistence of a negative selection process. Adv Stud Biol 2020;12:19–28.
  • Coutinho A. The Le Douarin phenomenon: a shift in the paradigm of developmental self-tolerance. Int J Dev Biol. 2005;49:5.
  • Vita R, Mahajan S, Overton JA, et al. The Immune Epitope Database (IEDB): 2018 update. Nucleic Acids Res. 2019;47:D339–D343.
  • Chen C, Li Z, Huang H, et al. UniProt consortium. A fast peptide match service for uniprot knowledgebase. Bioinformatics. 2013;29:2808–2809.
  • Stufano A, Capone G, Pesetti B, et al. Clustering of rare peptide segments in the HCV immunome. Self Nonself. 2010;1:154–162.
  • Lucchese A, Serpico R, Crincoli V, et al. Sequence uniqueness as a molecular signature of HIV-1-derived B-cell epitopes. Int J Immunopathol Pharmacol. 2009;22:639–646.
  • Lucchese G, Stufano A, Kanduc D. Proteome-guided search for influenza A B-cell epitopes. FEMS Immunol Med Microbiol. 2009;57:88–92.
  • Novello G, Capone G, Kanduc D. Reviewing the role of peptide rarity in bacterial toxin immunomics. Front Biosci. 2012;4:216–225.
  • Kanduc D. Pentapeptides as minimal functional units in cell biology and immunology. Curr Protein Pept Sci 2013;14:111–1420.
  • Immunogenicity KD. Immunopathogenicity, and immunotolerance in one graph. Anticancer Agents Med Chem. 2015;15:1264–1268.
  • Capone G, Novello G, Fasano C, et al. The oligodeoxynucleotide sequences corresponding to never expressed peptide motifs are mainly located in the non-coding strand. BMC Bioinformatics. 2010;11:383.
  • Hopp TP, Woods KR. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA. 1981;78:3824–3828.
  • Sanchez-Trincado JL, Gomez-Perosanz M, Reche PA. Fundamentals and methods for T- and B-cell epitope prediction. J Immunol Res. 2017;2017:2680160.
  • Kanduc D. Hydrophobicity and the physico-chemical basis of immunotolerance. Pathobiology. 2020;87:268–276.
  • Koshland DE Jr. Recognizing self from nonself. Science. 1990;248:1273.
  • Angelini G, Bonamonte D, Lucchese A, et al. Preliminary data on Pemphigus vulgaris treatment by a proteomics-defined peptide: a case report. J Transl Med. 2006;4:43.
  • Pan Y, Zhou Y, Wu H, et al. A therapeutic peptide vaccine against PCSK9. Sci Rep. 2017;7:12534.
  • Qiu Z, Chen X, Zhou Y, et al. Therapeutic vaccines against human and rat renin in spontaneously hypertensive rats. PLoS One. 2013;8:e66420.
  • Naor D, Hemed-Shaked M, Cowman M, et al. A human-derived 5-mer peptide (MTADV), which restrictively alleviates the pro-inflammatory activity of serum amyloid a (SAA), substantially ameliorates IBD pathology: new potential drug (MTADV) and therapeutic target candidate (SAA) for IBD. Inflamm Bowel Dis. 2020;26:S3–4.
  • Ahrens VM, Bellmann-Sickert K, Beck-Sickinger AG. Peptides and peptide conjugates: therapeutics on the upward path. Future Med Chem. 2012;4:1567–1586.
  • Drucker DJ. Advances in oral peptide therapeutics. Nat Rev Drug Discov. 2020;19:277–289.
  • Mahendran ASK, Lim YS, Fang CM, et al. The potential of antiviral peptides as COVID-19 therapeutics. Front Pharmacol. 2020;11:575444.
  • Natale C, Giannini T, Lucchese A, Kanduc D. Computer-assisted analysis of molecular mimicry between human papillomavirus 16 E7 oncoprotein and human protein sequences. Immunol Cell Biol. 2000 Dec;78(6):580-5. doi:10.1046/j.1440-1711.2000.00949.x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.